Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
about
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.Acute Kidney Injury and Progression of Diabetic Kidney Disease.The metabolomic quest for a biomarker in chronic kidney diseaseMetabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
P2860
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@en
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@nl
type
label
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@en
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@nl
prefLabel
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@en
Circulating Modified Metabolit ...... es and Chronic Kidney Disease.
@nl
P2093
P2860
P356
P1433
P1476
Circulating Modified Metabolit ...... tes and Chronic Kidney Disease
@en
P2093
Adam Smiles
Andrzej S Krolewski
Jaeman Byun
Joseph V Bonventre
Melissa Major
Monika A Niewczas
Stephanie Croall
Subramaniam Pennathur
Venkatta S Sabisetti
P2860
P304
P356
10.2337/DC16-0173
P407
P577
2017-01-13T00:00:00Z